1 Min Read
Oct 25 (Reuters) - Swedish Orphan Biovitrum Ab (Publ) says:
* Alprolix approved for treatment of Hemofili B in Saudi Arabia. Source text for Eikon: Further company coverage: (Reporting By Johan Sennero)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.